Call to scrap import tariffs on pharmaceuticals in global WTO talks

BMJ 2006; 332 doi: 10.1136/bmj.332.7540.508-c (Published 2 March 2006)
Cite this as: BMJ 2006;332:508.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John Zarocostas
  1. Geneva

    The United States, Switzerland, and Singapore this week called for an end to import tariffs that affect trade in drugs and medical devices worth more than $56bn (£32bn; €47bn) a year. Products covered by the tariffs include pharmaceutical goods, from antibiotics to vitamins, and medical devices, from surgical equipment and instruments to x ray equipment, hearing aids, and orthopaedic appliances.

    In a joint proposal, the countries said that scrapping the tariff would result in “effective action to improve access to medicines and medical devices needed to treat a wide variety of diseases effectively and ensure that these goods …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL